Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics The state has the second highest (and rising) cancer rates in the U.S.

Ozgur Sahin to co-lead Cancer Biology & Immunology program at MUSC Hollings

Ozgur Sahin was named co-leader of the Cancer Biology & Immunology Program at MUSC Hollings Cancer Center. Sahin joins Sophie Paczesny in that role.

June 12, 2026

Vol.52 No.23

Cancer Policy

Richard Pazdur joins Friends board

Friends of Cancer Research announced the election of Richard Pazdur to the organization’s board of directors.

June 05, 2026

Vol.52 No.22

By Claire Marie Porter

In Brief

Mina Sedrak and Vijaya Raj Bhatt to co-lead Alliance’s committee on cancer care for older adults

Mina Sedrak, director of the UCLA Center for Cancer and Aging and director of Cancer Control and Survivorship Research at the UCLA Health Jonsson Comprehensive Cancer Center, and Vijaya Raj Bhatt professor and medical director of the Leukemia Program at the University of Nebraska Medical Center, were selected to serve as co-chairs of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology.

June 05, 2026

Vol.52 No.22

In Brief

Katrina Armstrong to lead Vagelos Institute for Basic Biomedical Research at Columbia

Katrina Armstrong, Columbia University executive vice president for health and biomedical sciences, Columbia University Irving Medical Center CEO, and dean of the Vagelos College of Physicians and Surgeons, will transition from her current roles to launch the Vagelos Institute for Basic Biomedical Research, a collaboration between Roy and Diana Vagelos and the University.

June 05, 2026

Vol.52 No.22

Cancer Policy

FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure

In further major FDA shake-ups, three top regulators left the agency on May 15, just days after the resignation of Commissioner Marty Makary.

May 22, 2026

Vol.52 No.20

By Claire Marie Porter

In Brief

Charles Rudin named cancer center director at MSK

Charles Rudin was appointed director of Memorial Sloan Kettering Cancer Center, effective June 1.

May 22, 2026

Vol.52 No.20

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics

The state has the second highest (and rising) cancer rates in the U.S.

YOU MAY BE INTERESTED IN

Ozgur Sahin to co-lead Cancer Biology & Immunology program at MUSC Hollings

Richard Pazdur joins Friends board

Mina Sedrak and Vijaya Raj Bhatt to co-lead Alliance’s committee on cancer care for older adults

Katrina Armstrong to lead Vagelos Institute for Basic Biomedical Research at Columbia

FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure

Charles Rudin named cancer center director at MSK

Renew today!

Subscriber content

Never miss an issue!

Login